文献速递免疫规划妇幼与学校卫生卫生政策与健康促进

可能损害呼吸道合胞病毒抗体经胎盘转移的生物学因素:对中低收入国家孕产妇免疫政策与研究优先级的启示

Biological factors that may impair transplacental transfer of RSV antibodies: Implications for maternal immunization policy and research priorities for low- and middle-income countries.
PubMed 文献 · Vaccine · 2022-06-17

呼吸道合胞病毒(RSV)是全球婴儿急性下呼吸道感染的主要病毒病因,母婴免疫是预防早期婴儿RSV感染的有吸引力策略。本文综述了可能减弱或干扰保护性抗体从母体向胎儿转移的生物学因素,包括早产、低出生体重、母体HIV感染、胎盘疟疾和高丙种球蛋白血症,并指出中低收入国家这些因素流行且RSV死亡负担最重,强调需更多数据理解这些机制并提出了研究重点。

要点

  • RSV是全球婴儿急性下呼吸道感染的主要病毒病因,包括毛细支气管炎和肺炎。
  • 孕产妇免疫是预防早期婴儿RSV感染的有吸引力策略。
  • 早产、低出生体重、母体HIV感染、胎盘疟疾和高丙种球蛋白血症可能损害RSV抗体经胎盘转移。

核心结论

  • 多种生物学因素可能减弱或干扰保护性天然获得性抗体从母体向胎儿的转移,并可能通过损害疫苗诱导抗体的转移而降低疫苗有效性。
  • 中低收入国家这些因素流行且RSV相关死亡负担最重,需要更多数据以在RSV母婴免疫背景下理解这些机制。

研究设计与样本

  • 本文为综述,聚焦于目前已知的可能损害RSV抗体转移的生物学状况,包括早产、低出生体重、母体HIV感染、胎盘疟疾和高丙种球蛋白血症(母体总IgG高水平)。

主要发现

  • 早产、低出生体重、母体HIV感染、胎盘疟疾和高丙种球蛋白血症(母体总IgG高水平)是可能损害RSV抗体转移的生物学因素。
  • 许多上述因素在中低收入国家流行,而这些国家承受着最大的RSV相关死亡负担。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 需要更多数据以在RSV母婴免疫背景下理解这些机制。
  • 数据缺口包括对高丙种球蛋白血症的流行病学及其可能损害抗体转移的机制的理解有待改进。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Respiratory syncytial virus (RSV) is the leading viral cause of acute lower respiratory tract infection (ALRI), including bronchiolitis and pneumonia, in infants and children worldwide. Protection against RSV is primarily antibody mediated and passively acquired RSV neutralizing antibody can protect infants from RSV ALRI. Maternal immunization is an attractive strategy for the prevention of RSV in early infancy when immune responses to active immunization may be suboptimal and most severe RSV disease and death occur. However, several biologic factors have been shown to potentially attenuate or interfere with the transfer of protective naturally acquired antibodies from mother to fetus and could therefore also reduce vaccine effectiveness through impairment of transfer of vaccine-induced antibodies. Many of these factors are prevalent in low- and middle-income countries (LMIC) which experience the greatest burden of RSV-associated mortality; more data are needed to understand these mechanisms in the context of RSV maternal immunization. This review will focus on what is currently known about biologic conditions that may impair RSV antibody transfer, including preterm delivery, low birthweight, maternal HIV infection, placental malaria, and hypergammaglobulinemia (high levels of maternal total IgG). Key data gaps and priority areas for research are highlighted and include improved understanding of the epidemiology of hypergammaglobulinemia and the mechanisms by which it may impair antibody transfer. Key considerations for ensuring optimal vaccine effectiveness in LMICs are also discussed.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Atwell JE, Lutz CS, Sparrow EG, et al. Biological factors that may impair transplacental transfer of RSV antibodies: Implications for maternal immunization policy and research priorities for low- and middle-income countries. Vaccine. 2022. PMID: 35725783. doi:10.1016/j.vaccine.2022.06.034

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。